Cooperative Ovarian
Cancer Group
For an enhanced experience, get the free flash player
COGI's Overall Strategy
  • » Develop a strong Core Program that coordinates a network of clinical investigators
  • » Support and facilitate basic laboratory investigations
  • » Create partnerships with biotech industry that will support and utilize our group
  • » Recruit additional funding to expand our programs
We are now a member of GCIG (Gynecologic Cancer Intergroup).
Cooperative Ovarian Cancer Group

The Cooperative Ovarian Cancer Group (COGI), based at Stanford University, is a consortium of ovarian cancer researchers from 40 leading academic medical centers throughout the United States and United Kingdom, including Stanford University, Harvard University, Memorial Sloan Kettering Cancer Center, University of Pennsylvania, and the University of Washington. This group was formed in 2004 to focus on the development of vaccines and innovative immunotherapies for ovarian cancer.

Ten institutions are full COGI members and 30 institutions are affiliates. Since its inception, COGI has met annually as a group to plan strategy, and has supported laboratory programs, each of which will initiate a clinical vaccine trial directed for ovarian cancer.


Quick Links

Footer Links: